These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25897052)

  • 1. Ottawa wants your views on drug transparency.
    Eggertson L
    CMAJ; 2015 May; 187(8):E237-E238. PubMed ID: 25897052
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE is urged to make drug companies supply all trial data.
    O'Dowd A
    BMJ; 2012 Dec; 345():e8294. PubMed ID: 23223692
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug companies should release data from all trials of licensed drugs, say MPs.
    Hawkes N
    BMJ; 2013 Jan; 346():f321. PubMed ID: 23325880
    [No Abstract]   [Full Text] [Related]  

  • 4. Transparency in drug regulation: mirage or oasis?
    Lexchin J; Mintzes B
    CMAJ; 2004 Nov; 171(11):1363-5. PubMed ID: 15557590
    [No Abstract]   [Full Text] [Related]  

  • 5. Unlocking Health Canada's cache of trade secrets: mandatory disclosure of clinical trial results.
    Herder M
    CMAJ; 2012 Feb; 184(2):194-9. PubMed ID: 21876028
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug company drops case after EMA agrees to redactions in some documents to be published.
    Dyer C
    BMJ; 2014 Apr; 348():g2632. PubMed ID: 24709373
    [No Abstract]   [Full Text] [Related]  

  • 7. AbbVie considers harms to be commercially confidential information: sign a petition.
    Gøtzsche PC
    BMJ; 2013 Dec; 347():f7569. PubMed ID: 24366821
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies.
    Cohen K; Cormier JW; Davar MV
    J Contemp Health Law Policy; 2013; 29(2):201-32. PubMed ID: 23837261
    [No Abstract]   [Full Text] [Related]  

  • 9. Making available information from studies sponsored by the pharmaceutical industry: some current practices.
    O'Kelly M; Julious SA; Pyke S; Day S; Todd S; Seldrup J; Matcham J
    Pharm Stat; 2011; 10(1):60-9. PubMed ID: 21275036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Europe's drug regulator opens vaults of clinical-trials data.
    Abbott A
    Nature; 2016 Oct; 538(7626):440. PubMed ID: 27786232
    [No Abstract]   [Full Text] [Related]  

  • 11. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

  • 12. Putting GlaxoSmithKline to the test over paroxetine.
    Doshi P
    BMJ; 2013 Nov; 347():f6754. PubMed ID: 24222673
    [No Abstract]   [Full Text] [Related]  

  • 13. Health Canada wants more funds from pharma.
    Vogel L
    CMAJ; 2017 Jun; 189(24):E845-E846. PubMed ID: 28630367
    [No Abstract]   [Full Text] [Related]  

  • 14. More support for clinical trials in children.
    Nature; 2016 Jul; 535(7613):465-6. PubMed ID: 27466087
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data.
    Strech D; Littmann J
    Trials; 2012 Jul; 13():100. PubMed ID: 22747684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007.
    Meron D
    Seton Hall Law Rev; 2007; 37(4):929-39. PubMed ID: 18363219
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-company data vaults to be opened.
    Cressey D
    Nature; 2013 Mar; 495(7442):419-20. PubMed ID: 23538802
    [No Abstract]   [Full Text] [Related]  

  • 18. More transparency for clinical trial data: The decision by the European Medicines Agency to make clinical trial reports publicly available could provide a boon for biomedical research.
    Hunter P
    EMBO Rep; 2015 Jan; 16(1):21-3. PubMed ID: 25476710
    [No Abstract]   [Full Text] [Related]  

  • 19. Transparency campaigners welcome new rules for clinical trials in Europe.
    Kmietowicz Z
    BMJ; 2014 Apr; 348():g2579. PubMed ID: 24699321
    [No Abstract]   [Full Text] [Related]  

  • 20. Access to information and the right to health: the human rights case for clinical trials transparency.
    Lemmens T; Telfer C
    Am J Law Med; 2012; 38(1):63-112. PubMed ID: 22497094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.